72657-168-50 : NDC 2026 Code

72657-168-50 : Olopatadine Hydrochloride Ophthalmic ( Olopatadine Hydrochloride )

Additionally :

You can get information about “72657-168-50” NDC code in 72657-168-50 in HTML format

HTML | 72657-168-50 in TXT (Plain Text) format

TXT | 72657-168-50 in PDF (Portable Document Format)

PDF | 72657-168-50 in XML format

XML formats.

NDC Code : 72657-168-50 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72657-168-50",
    "PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (72657-168-50)  / 5 mL in 1 BOTTLE, PLASTIC",
    "NDC11Code": "72657-0168-50",
    "ProductNDC": "72657-168",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Olopatadine Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Olopatadine Hydrochloride Ophthalmic",
    "DosageFormName": "SOLUTION",
    "RouteName": "OPHTHALMIC",
    "StartMarketingDate": "20240726",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA200810",
    "LabelerName": "GLENMARK THERAPEUTICS INC., USA",
    "SubstanceName": "OLOPATADINE HYDROCHLORIDE",
    "StrengthNumber": "1",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-02-10",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20240726",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}